Glimepiride Tablets, USP 1mg, 500-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam-532 409 INDIA, NDC: 55111-320-05
Published February 14, 2024 · Recall initiated: January 18, 2024
Summary
FDA records drug Class III recall D-0313-2024, published February 14, 2024 and initiated January 18, 2024. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Ongoing; Reported quantity: 14,425 bottles; Lot: Lot: T2303609; Exp. 06/2026 Lot: T2303610; Exp. 06/2026. Class III means the product is not likely to cause adverse health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Misprint on tablet
What to do
Voluntary: Firm initiated · Letter
Get an email if GLIMEPIRIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- GLIMEPIRIDE
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Distributor
- Nationwide
- Lot
- Lot: T2303609; Exp. 06/2026 Lot: T2303610; Exp. 06/2026
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAGlimepiride Tablets, USP 1mg, 100-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited,February 14, 2024
- FDAFebuxostat Tablets, 40 mg, 30 Tablets (3 x 10) per carton, Rx only, Distributed by: American Health Packaging,February 14, 2024
- FDAUp&Up brand dry eye relief (Carboxymethylcellulose 0.5%) packaged in 0.5 FL OZ (15 mL) each bottles (TwinFebruary 14, 2024
- FDAGlimepiride Tablets, USP 4mg, packaged in a) 30-count bottles (NDC 51655-120-52), and b) 90-count bottles (NDCMay 3, 2023
- FDAGlimepiride Tablets, USP 2mg, packaged in a) 30-count bottles (NDC 51655-383-52), and b)90-count bottles (NDCMay 3, 2023
- FDAGlimepiride Tablets USP, 2 mg, Rx Only, Packaged in: a) 100 Tablets NDC 16729-002-01 UPC 3 16729 00201 1; b)March 8, 2023
Questions about this recall
Was Glimepiride Tablets, USP 1mg, 500-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam-532 409 INDIA, NDC: 55111-320-05 recalled?
Yes. FDA published recall D-0313-2024 on February 14, 2024. Reported hazard: Misprint on tablet
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: GLIMEPIRIDE.